Literature DB >> 28355566

Enhanced Degradation of Misfolded Proteins Promotes Tumorigenesis.

Liang Chen1, Michael D Brewer1, Lili Guo1, Ruoxing Wang1, Peng Jiang1, Xiaolu Yang2.   

Abstract

An adequate cellular capacity to degrade misfolded proteins is critical for cell survival and organismal health. A diminished capacity is associated with aging and neurodegenerative diseases; however, the consequences of an enhanced capacity remain undefined. Here, we report that the ability to clear misfolded proteins is increased during oncogenic transformation and is reduced upon tumor cell differentiation. The augmented capacity mitigates oxidative stress associated with oncogenic growth and is required for both the initiation and maintenance of malignant phenotypes. We show that tripartite motif-containing (TRIM) proteins select misfolded proteins for proteasomal degradation. The higher degradation power in tumor cells is attributed to the upregulation of the proteasome and especially TRIM proteins, both mediated by the antioxidant transcription factor Nrf2. These findings establish a critical role of TRIMs in protein quality control, connect the clearance of misfolded proteins to antioxidant defense, and suggest an intrinsic characteristic of tumor cells.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nrf2; PML; ROS; TRIM proteins; TRIM11; breast cancer; misfolded proteins; proteasome; protein quality control; transformation

Mesh:

Substances:

Year:  2017        PMID: 28355566      PMCID: PMC5603913          DOI: 10.1016/j.celrep.2017.03.010

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  42 in total

Review 1.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 2.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 3.  Autophagy at the crossroads of catabolism and anabolism.

Authors:  Jasvinder Kaur; Jayanta Debnath
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07-15       Impact factor: 94.444

4.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

Review 5.  The biology of proteostasis in aging and disease.

Authors:  Johnathan Labbadia; Richard I Morimoto
Journal:  Annu Rev Biochem       Date:  2015-03-12       Impact factor: 23.643

6.  MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1.

Authors:  Zijian Tang; Siyuan Dai; Yishu He; Rosalinda A Doty; Leonard D Shultz; Stephen Byers Sampson; Chengkai Dai
Journal:  Cell       Date:  2015-02-12       Impact factor: 41.582

Review 7.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

8.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

9.  HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.

Authors:  Marc L Mendillo; Sandro Santagata; Martina Koeva; George W Bell; Rong Hu; Rulla M Tamimi; Ernest Fraenkel; Tan A Ince; Luke Whitesell; Susan Lindquist
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

10.  Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.

Authors:  Chengkai Dai; Luke Whitesell; Arlin B Rogers; Susan Lindquist
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

View more
  32 in total

1.  TRIM11 cooperates with HSF1 to suppress the anti-tumor effect of proteotoxic stress drugs.

Authors:  Liang Chen; Xiaolu Yang
Journal:  Cell Cycle       Date:  2018-12-26       Impact factor: 4.534

Review 2.  Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.

Authors:  Evert Njomen; Jetze J Tepe
Journal:  J Med Chem       Date:  2019-03-14       Impact factor: 7.446

3.  Augmented capacity to clear misfolded proteins: An intrinsic characteristic of tumor cells?

Authors:  Liang Chen; Lili Guo; Xiaolu Yang
Journal:  Mol Cell Oncol       Date:  2017-08-31

Review 4.  TRIM proteins in autophagy: selective sensors in cell damage and innate immune responses.

Authors:  Martina Di Rienzo; Alessandra Romagnoli; Manuela Antonioli; Mauro Piacentini; Gian Maria Fimia
Journal:  Cell Death Differ       Date:  2020-01-22       Impact factor: 15.828

5.  TRIM32, but not its muscular dystrophy-associated mutant, positively regulates and is targeted to autophagic degradation by p62/SQSTM1.

Authors:  Katrine Stange Overå; Juncal Garcia-Garcia; Zambarlal Bhujabal; Ashish Jain; Aud Øvervatn; Kenneth Bowitz Larsen; Vojo Deretic; Terje Johansen; Trond Lamark; Eva Sjøttem
Journal:  J Cell Sci       Date:  2019-12-02       Impact factor: 5.285

6.  TRIM16 controls turnover of protein aggregates by modulating NRF2, ubiquitin system, and autophagy: implication for tumorigenesis.

Authors:  Kautilya Kumar Jena; Srinivasa Prasad Kolapalli; Subhash Mehto; Swati Chauhan; Santosh Chauhan
Journal:  Mol Cell Oncol       Date:  2018-10-22

7.  A new pyridazinone exhibits potent cytotoxicity on human cancer cells via apoptosis and poly-ubiquitinated protein accumulation.

Authors:  Denisse A Gutierrez; Rebecca E DeJesus; Lisett Contreras; Isela A Rodriguez-Palomares; Paulina J Villanueva; Karol S Balderrama; Lenore Monterroza; Manuel Larragoity; Armando Varela-Ramirez; Renato J Aguilera
Journal:  Cell Biol Toxicol       Date:  2019-03-01       Impact factor: 6.691

8.  Codon misreading tRNAs promote tumor growth in mice.

Authors:  Mafalda Santos; Patricia M Pereira; A Sofia Varanda; Joana Carvalho; Mafalda Azevedo; Denisa D Mateus; Nuno Mendes; Patricia Oliveira; Fábio Trindade; Marta Teixeira Pinto; Renata Bordeira-Carriço; Fátima Carneiro; Rui Vitorino; Carla Oliveira; Manuel A S Santos
Journal:  RNA Biol       Date:  2018-06-07       Impact factor: 4.652

9.  Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer.

Authors:  Yadong Xie; Yifan Zhao; Lei Shi; Wei Li; Kun Chen; Min Li; Xia Chen; Haiwei Zhang; Tiantian Li; Yu Matsuzawa-Ishimoto; Xiaomin Yao; Dianhui Shao; Zunfu Ke; Jian Li; Yan Chen; Xiaoming Zhang; Jun Cui; Shuzhong Cui; Qibin Leng; Ken Cadwell; Xiaoxia Li; Hong Wei; Haibing Zhang; Huabin Li; Hui Xiao
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 10.  Trash Talk: Mammalian Proteasome Regulation at the Transcriptional Level.

Authors:  Hatem Elif Kamber Kaya; Senthil K Radhakrishnan
Journal:  Trends Genet       Date:  2020-09-25       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.